Consensus Carl Zeiss Meditec AG

Equities

AFX

DE0005313704

Market Closed - Xetra 11:38:30 2024-04-19 am EDT 5-day change 1st Jan Change
97.7 EUR +0.05% Intraday chart for Carl Zeiss Meditec AG -4.50% -1.15%

Evolution of the average Target Price on Carl Zeiss Meditec AG

Price target over the last 5 years

History of analyst recommendation changes

1629748b1c41b6b142f.UpslzXw0CwTdyJRyJQdOdr61T6m5wMqtthm7BJjgbX0.Fs0XhkkAJkiIscYQaG14RpPGJ87hrKnL22zNTamPWDsj40KqLl94PJWR5w~17daa8f685d0a029c898cd7cb55a208a
CARL ZEISS MEDITEC : Potential remains intact, despite some near-term jitters Alphavalue
CARL ZEISS MEDITEC AG : Deutsche Bank sticks Neutral ZD
CARL ZEISS MEDITEC AG : Gets a Buy rating from DZ Bank ZD
CARL ZEISS MEDITEC AG : UBS maintains a Buy rating ZD
Goldman starts Carl Zeiss Meditec with 'Neutral' - Target 110 euros DP
CARL ZEISS MEDITEC AG : Upgraded to Neutral by Goldman Sachs ZD
JPMorgan raises target for Carl Zeiss Meditec - 'Underweight' DP
CARL ZEISS MEDITEC AG : JP Morgan gives a Sell rating ZD
CARL ZEISS MEDITEC AG : RBC reiterates its Buy rating ZD
RBC starts Carl Zeiss Meditec with 'Outperform' - Target 150 Euro DP
CARL ZEISS MEDITEC AG : RBC remains its Buy rating ZD
HSBC lowers Carl Zeiss Meditec to 'Hold' - target raised to 120 euros DP
CARL ZEISS MEDITEC AG : Hauck & Aufhauser remains its Buy rating ZD
Berenberg raises target for Carl Zeiss Meditec to 105 euros - 'Hold' DP
CARL ZEISS MEDITEC AG : Gets a Neutral rating from Berenberg ZD
CARL ZEISS MEDITEC : Carl Zeiss Meditec’s re-rating journey should continue further Alphavalue
CARL ZEISS MEDITEC AG : UBS keeps its Buy rating ZD
CARL ZEISS MEDITEC AG : Deutsche Bank sticks Neutral ZD
CARL ZEISS MEDITEC AG : Buy rating from Hauck & Aufhauser ZD
CARL ZEISS MEDITEC AG : Deutsche Bank sticks Neutral ZD
JPMorgan raises Carl Zeiss Meditec target to 59 euros - 'Underweight' DP
CARL ZEISS MEDITEC AG : JP Morgan maintains a Sell rating ZD
CARL ZEISS MEDITEC AG : Sell rating from Bernstein ZD
CARL ZEISS MEDITEC AG : Berenberg sticks Neutral ZD
CARL ZEISS MEDITEC : Despite the profitability miss, FY 23/24 guidance unchanged Alphavalue
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
97.7 EUR
Average target price
108.7 EUR
Spread / Average Target
+11.22%
High Price Target
150 EUR
Spread / Highest target
+53.53%
Low Price Target
70 EUR
Spread / Lowest Target
-28.35%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Carl Zeiss Meditec AG

alphavalue Anas Patel
DEUTSCHE BANK RESEARCH Falko Friedrichs
DZ BANK Sven Kürten
UBS Graham Doyle
GOLDMAN SACHS Richard Felton
JPMORGAN Anchal Verma
RBC Jack Reynolds-Clark
HAUCK AUFHÄUSER INVESTMENT BANKING Alexander Galitsa
BERENBERG Sam England
BERNSTEIN RESEARCH Susannah Ludwig
BANK OF AMERICA (BOFA) Julien Ouaddour
HAUCK AUFHÄUSER LAMPE Alexander Galitsa
DEUTSCHE BANK Falko Friedrichs
HSBC Sezgi Oezener
KEPLER CHEUVREUX Oliver Reinberg
NORDLB Holger Fechner
HAUCK & AUFHÄUSER Aliaksandr Halitsa
INDEPENDENT RESEARCH Tobias Gottschalt
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
  1. Stock Market
  2. Equities
  3. AFX Stock
  4. Consensus Carl Zeiss Meditec AG